Create your Personal Health Record and unlock support built around you

  • Treatments and trials you qualify for
  • Education for your stage of care
  • Financial support for your medications
  • Solutions to your side effects
Learn more about HealthTree
Targeted Therapy Combinations: VVIP, VIPOR, and VIPOR-P Clinical Trials image

Targeted Therapy Combinations: VVIP, VIPOR, and VIPOR-P Clinical Trials

Posted on: Apr 12, 2024
Play Episode
Also available on
play podcast in spotifySpotify
Description

This event was recorded on April 10th, 2024.

In this podcast episode, Dr. Christopher Melani shares about three important trials he has been working on at The National Institute of Health in Bethesda, Maryland. The VVIP, VIPOR, and VIPOR-P studies are targeted therapy combinations that could be the future of lymphoma treatment. We discuss the trial designs, patient eligibility, and how these new treatments could improve lymphoma patient outcomes.

Thank you to our episode sponsors, Regeneron, and Bristol Myers Squibb.

Overview

Dr. Melani discusses the latest updates from the VVIP, VIPOR, and VIPOR-P studies, which are clinical trials for non-Hodgkin's lymphoma. The goal of these studies is to improve the outcome for patients with relapsed or refractory lymphomas by using targeted therapy combinations. The targeted therapies block specific proteins that cancer cells need to grow and survive. The conversation also discusses these three clinical trials' design and treatment protocols.

On this episode
Healthtree contact Dr. Christopher Melani

Dr. Christopher Melani

Dr. Melani is a Staff Clinician and a clinical researcher specializing in lymphoma. His areas of interest include the use of novel therapies and drug combinations for the treatment of lymphomas as well as novel methods of molecular monitoring of disease and response to treatment, such as circulating tumor DNA (ctDNA).
Healthtree contact Kat Richardson

Kat Richardson

Kat is from Lehi, Utah and is the Health Education Manager for lymphoma. She has worked in healthcare for a decade now, and earned her degree in Community Health Education and Promotion. Kat is passionate about disease prevention as well as improving quality of life and health equity. She enjoys reading, hiking, baking, ice skating, gardening, time with her family and friends, and most of all, spoiling her nieces and nephew. 
Transcript

Related Content